Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 31, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 13, 2018
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers.
Journal: OncoTargets and therapy
Published: April 25, 2017
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
Journal: Current oncology reports
Published: March 18, 2017
Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 30, 2015
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 29, 2014
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: January 21, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026